TSC
Two Seas Capital’s Arbutus Biopharma ABUS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.3M | Buy |
10,443,317
+977,361
| +10% | +$3.02M | 0.54% | 12 |
|
|
2025
Q1 | $33M | Buy |
9,465,956
+725,000
| +8% | +$2.53M | 1.04% | 8 |
|
|
2024
Q4 | $28.6M | Buy |
8,740,956
+353,568
| +4% | +$1.16M | 2.47% | 10 |
|
|
2024
Q3 | $32.3M | Sell |
8,387,388
-184,363
| -2% | -$710K | 5.23% | 5 |
|
|
2024
Q2 | $26.5M | Buy |
8,571,751
+729,824
| +9% | +$2.26M | 4.3% | 7 |
|
|
2024
Q1 | $20.2M | Sell |
7,841,927
-1,200,000
| -13% | -$3.1M | 3.96% | 3 |
|
|
2023
Q4 | $22.6M | Buy |
9,041,927
+761,109
| +9% | +$1.9M | 5.52% | 4 |
|
|
2023
Q3 | $16.8M | Hold |
8,280,818
| – | – | 3.38% | 3 |
|
|
2023
Q2 | $19M | Buy |
8,280,818
+816,094
| +11% | +$1.88M | 4.16% | 3 |
|
|
2023
Q1 | $22.6M | Sell |
7,464,724
-39,469
| -0.5% | -$120K | 20.76% | 2 |
|
|
2022
Q4 | $17.5M | Buy |
7,504,193
+1,850,276
| +33% | +$4.31M | 16.61% | 2 |
|
|
2022
Q3 | $10.8M | Buy |
5,653,917
+2,152,041
| +61% | +$4.11M | 9.86% | 4 |
|
|
2022
Q2 | $9.49M | Buy |
3,501,876
+1,302,807
| +59% | +$3.53M | 12.35% | 4 |
|
|
2022
Q1 | $6.55M | Buy |
2,199,069
+1,373,500
| +166% | +$4.09M | 5.49% | 3 |
|
|
2021
Q4 | $3.21M | Buy |
+825,569
| New | +$3.21M | 2.46% | 4 |
|